RankingsPricing
  1. JP-listed companies
  2. KYORIN Pharmaceutical Co., Ltd.
  3. Financials
  4. Payments for dividends

KYORIN Pharmaceutical Co., Ltd.【JP:4569】

Market cap
¥105.3B
P/E ratio
19.5x
SummaryFinancialsDividendsHistoryOwnershipWorkforce
Period EndPayments for dividends (Million JPY)YoY (%)
Mar 31, 2025-3,015+0.07%
Mar 31, 2024-3,013-0.07%
Mar 31, 2023-3,015-19.96%
Mar 31, 2022-3,767-13.34%
Mar 31, 2021-4,347+0.02%
Mar 31, 2020-4,346-14.25%
Mar 31, 2019-5,068+17.18%
Mar 31, 2018-4,325+0.07%
Mar 31, 2017-4,322+11.51%
Mar 31, 2016-3,876-16.21%
Mar 31, 2015-4,626

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)